WSO - July 2023 - 650

650
International Journal of Stroke 18(6)
International Journal of Stroke, 18(6)
Table 2. Summary of the epidemiological data from study periods assessing the incidence in Latin America and the Caribbean.
Periods
Study and
publication year
Country
(City)
Study period No. Of
cases of
stroke
identified
1. Bahit et al.16
Argentina
(Tandil)
2. Corbin et al.17
Barbados
1
2013-2015
334
Population
denominator
Mean (SD)
age (years)
Female, N
(%)
CT
available
(%)
261,182
72.2 (14.4)
175 (52.4)
97.1
Stroke type
N (%)
Crude annual
incidence/100,000,
N (95% CI)
IS 251 (75)
ICH 54 (16)
SAH 17 (5)
1
2001-2002
352
26,8792
72.5 (14.8)
210 (59.7)
92.6
IS, 288 (82)
ICH. 42 (12)
SAH, 7 (2)
3. Cabral et al.18
Brazil
(Joinville)
2
2012-2013
922
1,073,318
63.7 (15.5)
450 (48.8)
99.0
1
2005-2006
759
987,619
64.9 (13.9)
367 (48.4)
98.0
IS, 610 (80)
ICH, 94 (12)
SAH, 50 (7)
IS, 786 (85)
ICH, 84 (9)
SAH, 52 (7)
4. Minelli et al.19
Brazil
(Matao)
1
2003-2004
81
76,786
65.2 (11.8)
30 (37.0)
NS
IS, 69 (85)
ICH, 11 (14)
SAH, 1 (1)
2
2015-2016
81
78,890
71 (13.1)
40 (50.6)
NS
IS, 67 (83)
ICH, 10 (12)
SAH, 4 (5)
5. Lavados et al.20
Chile
(Iquique)
6. Lavados et al.21
Chile
(Ñuble)
7. Olindo et al.22
Martinique
1
1998-1999
580
362,259
71.2 (14)
295 (50.9)
92.8
1
2015-2016
890
49,3464
70.3 (14.1)
443 (49.8)
90.0
1
2000-2002
292
396,712
64.8 (5.1)
128 (44)
91.0
IS, 185 (63)
ICH, 69 (24)
SAH, 15 (5)
IS 639 (72)
HIC 111 (12)
SAH 47 (5)
IS, 463 (80)
HIC, 83 (14)
SAH, 20 (3)
2
2011-2012
544
370,854
72 (15)
252 (46.3)
99.4
IS, 439 (81)
HIC, 84 (15)
SAH, 14 (3)
*SEGI " world " population as standards.
¥Only one ethnic group represented (n = 335 cases).
127.9 (114.5-142.3)
Sex-disaggregated
incidence rate
female/105, N (95%
CI)
129.8 (111.2-150.5)
Sex-disaggregated
incidence rate male/
105, N (95% CI)
125.9 (61.7-86.1)
Age-adjusted
incidence/105, N
(95% CI)*
NS
One-month
case-fatality
(95% CI)
20.1 (15.9-24.8)
131.0 (117.6-145.4)
163.2 (141.5-187.2) ¥
115.0 (96.3-136.4) ¥ NS
NS
76.9 (71.5-82.5)
73.5 (66.2-81.4)
80.2 (72.5-88.5)
105.4 (98-113.2)
19.1 (16.0-22.4)
85.9 (80.4-91.6)
83.3 (75.8-91.4)
88.6 (80.8-97.0)
90.9 (85.1-96.9)
NS
105.5 (83.8-131.1)
66.4 (49.4-87.3)
39.0 (26.3-55.7)
NS
18.5 (10.8-28.7)
102.7 (81.5-127.6)
50.7 (36.2-69.0)
51.9 (37.3-70.5)
NS
17.3 (9.8-27.3)
73.6 (65.4-82.5)
65.3 (53.9-76.6)
81.8 (69.3-94.3)
94.1 (83.3-104.9)
23.3 (18.6-28.6)
180.4 (168.7-192.6)
175.2 (159.3-192.3)
185.8 (168.9-203.8)
254.1 (237.4-271.1)
24.6 (21.8-27.6)
160.1 (147.3-173.7)
154.9 (138-182)
165.8 (146-186)
111 (102-120)
NS
146.7 (134.6-159.5)
125.7 (110-141)
171.2 (152-190
77 (70-84)
NS
NS: not stated; IS: ischemic stroke; ICH: intracerebral hemorrhage; CVT: cerebral venous thrombosis; SAH: subarachnoid hemorrhage; US: unspecified stroke type; SD: standard deviation; CI: confidence interval.

WSO - July 2023

Table of Contents for the Digital Edition of WSO - July 2023

Contents
WSO - July 2023 - Cover1
WSO - July 2023 - Cover2
WSO - July 2023 - 627
WSO - July 2023 - Contents
WSO - July 2023 - 629
WSO - July 2023 - 630
WSO - July 2023 - 631
WSO - July 2023 - 632
WSO - July 2023 - 633
WSO - July 2023 - 634
WSO - July 2023 - 635
WSO - July 2023 - 636
WSO - July 2023 - 637
WSO - July 2023 - 638
WSO - July 2023 - 639
WSO - July 2023 - 640
WSO - July 2023 - 641
WSO - July 2023 - 642
WSO - July 2023 - 643
WSO - July 2023 - 644
WSO - July 2023 - 645
WSO - July 2023 - 646
WSO - July 2023 - 647
WSO - July 2023 - 648
WSO - July 2023 - 649
WSO - July 2023 - 650
WSO - July 2023 - 651
WSO - July 2023 - 652
WSO - July 2023 - 653
WSO - July 2023 - 654
WSO - July 2023 - 655
WSO - July 2023 - 656
WSO - July 2023 - 657
WSO - July 2023 - 658
WSO - July 2023 - 659
WSO - July 2023 - 660
WSO - July 2023 - 661
WSO - July 2023 - 662
WSO - July 2023 - 663
WSO - July 2023 - 664
WSO - July 2023 - 665
WSO - July 2023 - 666
WSO - July 2023 - 667
WSO - July 2023 - 668
WSO - July 2023 - 669
WSO - July 2023 - 670
WSO - July 2023 - 671
WSO - July 2023 - 672
WSO - July 2023 - 673
WSO - July 2023 - 674
WSO - July 2023 - 675
WSO - July 2023 - 676
WSO - July 2023 - 677
WSO - July 2023 - 678
WSO - July 2023 - 679
WSO - July 2023 - 680
WSO - July 2023 - 681
WSO - July 2023 - 682
WSO - July 2023 - 683
WSO - July 2023 - 684
WSO - July 2023 - 685
WSO - July 2023 - 686
WSO - July 2023 - 687
WSO - July 2023 - 688
WSO - July 2023 - 689
WSO - July 2023 - 690
WSO - July 2023 - 691
WSO - July 2023 - 692
WSO - July 2023 - 693
WSO - July 2023 - 694
WSO - July 2023 - 695
WSO - July 2023 - 696
WSO - July 2023 - 697
WSO - July 2023 - 698
WSO - July 2023 - 699
WSO - July 2023 - 700
WSO - July 2023 - 701
WSO - July 2023 - 702
WSO - July 2023 - 703
WSO - July 2023 - 704
WSO - July 2023 - 705
WSO - July 2023 - 706
WSO - July 2023 - 707
WSO - July 2023 - 708
WSO - July 2023 - 709
WSO - July 2023 - 710
WSO - July 2023 - 711
WSO - July 2023 - 712
WSO - July 2023 - 713
WSO - July 2023 - 714
WSO - July 2023 - 715
WSO - July 2023 - 716
WSO - July 2023 - 717
WSO - July 2023 - 718
WSO - July 2023 - 719
WSO - July 2023 - 720
WSO - July 2023 - 721
WSO - July 2023 - 722
WSO - July 2023 - 723
WSO - July 2023 - 724
WSO - July 2023 - 725
WSO - July 2023 - 726
WSO - July 2023 - 727
WSO - July 2023 - 728
WSO - July 2023 - 729
WSO - July 2023 - 730
WSO - July 2023 - 731
WSO - July 2023 - 732
WSO - July 2023 - 733
WSO - July 2023 - 734
WSO - July 2023 - 735
WSO - July 2023 - 736
WSO - July 2023 - 737
WSO - July 2023 - 738
WSO - July 2023 - 739
WSO - July 2023 - 740
WSO - July 2023 - 741
WSO - July 2023 - 742
WSO - July 2023 - 743
WSO - July 2023 - 744
WSO - July 2023 - 745
WSO - July 2023 - 746
WSO - July 2023 - 747
WSO - July 2023 - 748
WSO - July 2023 - 749
WSO - July 2023 - 750
WSO - July 2023 - 751
WSO - July 2023 - 752
WSO - July 2023 - 753
WSO - July 2023 - 754
WSO - July 2023 - 755
WSO - July 2023 - 756
WSO - July 2023 - Cover3
WSO - July 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com